Copyright
©The Author(s) 2017.
World J Gastroenterol. Apr 21, 2017; 23(15): 2763-2770
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2763
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2763
HBV (%) | HCV (%) | Non-viral (%) | P value | |
Size of dominant lesion | ||||
< 1 cm | 1.3 | 2.8 | 2.6 | < 0.001 |
1-3 cm | 34.4 | 46.5 | 32.1 | < 0.001 |
3-5 cm | 22.4 | 23.8 | 20.5 | < 0.001 |
> 5 cm | 32.0 | 18.0 | 34.0 | < 0.001 |
Unknown | 10.0 | 9.2 | 10.4 | < 0.001 |
Tumor extent > 50% | 12.4 | 4.2 | 12.5 | < 0.001 |
Vascular invasion | 10.4 | 6.7 | 12.3 | < 0.020 |
- Citation: Mohsen W, Rodov M, Prakoso E, Charlton B, Bowen DG, Koorey DJ, Shackel NA, McCaughan GW, Strasser SI. Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma. World J Gastroenterol 2017; 23(15): 2763-2770
- URL: https://www.wjgnet.com/1007-9327/full/v23/i15/2763.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i15.2763